65 related articles for article (PubMed ID: 28350335)
21. Under-Reported Aspects of Platinum Drug Pharmacology.
Theile D
Molecules; 2017 Feb; 22(3):. PubMed ID: 29760371
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of human topoisomerase I and II and anti-proliferative effects on MCF-7 cells by new titanocene complexes.
Chimento A; Saturnino C; Iacopetta D; Mazzotta R; Caruso A; Plutino MR; Mariconda A; Ramunno A; Sinicropi MS; Pezzi V; Longo P
Bioorg Med Chem; 2015 Nov; 23(22):7302-12. PubMed ID: 26526741
[TBL] [Abstract][Full Text] [Related]
23. Triple negative breast cancer: looking for the missing link between biology and treatments.
Palma G; Frasci G; Chirico A; Esposito E; Siani C; Saturnino C; Arra C; Ciliberto G; Giordano A; D'Aiuto M
Oncotarget; 2015 Sep; 6(29):26560-74. PubMed ID: 26387133
[TBL] [Abstract][Full Text] [Related]
24. Different 6-Aryl-Fulvenes Exert Anti-proliferative effects on Cancer Cells.
Sirignano E; Pisano A; Caruso A; Saturnino C; Sinicropi MS; Lappano R; Botta A; Iacopetta D; Maggiolini M; Longo P
Anticancer Agents Med Chem; 2015; 15(4):468-74. PubMed ID: 25329489
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of cytotoxic activities of new guanidines derived from carbazoles.
Caruso A; Sinicropi MS; Lancelot JC; El-Kashef H; Saturnino C; Aubert G; Ballandonne C; Lesnard A; Cresteil T; Dallemagne P; Rault S
Bioorg Med Chem Lett; 2014 Jan; 24(2):467-72. PubMed ID: 24374274
[TBL] [Abstract][Full Text] [Related]
26. New titanocene derivatives with high antiproliferative activity against breast cancer cells.
Saturnino C; Sirignano E; Botta A; Sinicropi MS; Caruso A; Pisano A; Lappano R; Maggiolini M; Longo P
Bioorg Med Chem Lett; 2014 Jan; 24(1):136-40. PubMed ID: 24332626
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, characterization and cytotoxic activity on breast cancer cells of new half-titanocene derivatives.
Sirignano E; Saturnino C; Botta A; Sinicropi MS; Caruso A; Pisano A; Lappano R; Maggiolini M; Longo P
Bioorg Med Chem Lett; 2013 Jun; 23(11):3458-62. PubMed ID: 23623493
[TBL] [Abstract][Full Text] [Related]
28. Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes.
Shen DW; Pouliot LM; Hall MD; Gottesman MM
Pharmacol Rev; 2012 Jul; 64(3):706-21. PubMed ID: 22659329
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, DNA binding, photo-induced DNA cleavage and cell cytotoxicity studies of a family of light rare earth complexes.
Chen GJ; Qiao X; Gao CY; Xu GJ; Wang ZL; Tian JL; Xu JY; Gu W; Liu X; Yan SP
J Inorg Biochem; 2012 Apr; 109():90-6. PubMed ID: 22440521
[TBL] [Abstract][Full Text] [Related]
30. Photoactivated DNA cleavage and anticancer activity of pyrenyl-terpyridine lanthanide complexes.
Hussain A; Gadadhar S; Goswami TK; Karande AA; Chakravarty AR
Eur J Med Chem; 2012 Apr; 50():319-31. PubMed ID: 22381356
[TBL] [Abstract][Full Text] [Related]
31. Liposomes as a model for the biological membrane: studies on daunorubicin bilayer interaction.
Matos C; Moutinho C; Lobão P
J Membr Biol; 2012 Feb; 245(2):69-75. PubMed ID: 22210277
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, characterization and preliminary cytotoxicity evaluation of five lanthanide(III)-plumbagin complexes.
Chen ZF; Tan MX; Liu YC; Peng Y; Wang HH; Liu HG; Liang H
J Inorg Biochem; 2011 Mar; 105(3):426-34. PubMed ID: 21421129
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, characterization and cytotoxicity studies of methoxy alkyl substituted metallocenes.
Napoli M; Saturnino C; Sirignano E; Popolo A; Pinto A; Longo P
Eur J Med Chem; 2011 Jan; 46(1):122-8. PubMed ID: 21094563
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and cytotoxic activities of group 3 metal complexes having monoanionic tridentate ligands.
Saturnino C; Napoli M; Paolucci G; Bortoluzzi M; Popolo A; Pinto A; Longo P
Eur J Med Chem; 2010 Sep; 45(9):4169-74. PubMed ID: 20591537
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxicity in human cancer cells and mitochondrial dysfunction induced by a series of new copper(I) complexes containing tris(2-cyanoethyl)phosphines.
Zanella A; Gandin V; Porchia M; Refosco F; Tisato F; Sorrentino F; Scutari G; Rigobello MP; Marzano C
Invest New Drugs; 2011 Dec; 29(6):1213-23. PubMed ID: 20567997
[TBL] [Abstract][Full Text] [Related]
36. Platinum neurotoxicity pharmacogenetics.
McWhinney SR; Goldberg RM; McLeod HL
Mol Cancer Ther; 2009 Jan; 8(1):10-6. PubMed ID: 19139108
[TBL] [Abstract][Full Text] [Related]
37. Theoretical, spectral characterization and antineoplastic activity of new lanthanide complexes.
Kostova I; Trendafilova N; Momekov G
J Trace Elem Med Biol; 2008; 22(2):100-11. PubMed ID: 18565422
[TBL] [Abstract][Full Text] [Related]
38. Oxali-titanocene Y: a potent anticancer drug.
Claffey J; Hogan M; Müller-Bunz H; Pampillón C; Tacke M
ChemMedChem; 2008 May; 3(5):729-31. PubMed ID: 18186097
[No Abstract] [Full Text] [Related]
39. A study of the role of apoptotic cell death and cell cycle events mediating the mechanism of action of 6-hydroxycoumarin-3-carboxylatosilver in human malignant hepatic cells.
Thati B; Noble A; Creaven BS; Walsh M; McCann M; Kavanagh K; Devereux M; Egan DA
Cancer Lett; 2007 May; 250(1):128-39. PubMed ID: 17126993
[TBL] [Abstract][Full Text] [Related]
40. Heteroaryl substituted titanocenes as potential anti-cancer drugs.
Sweeney N; Gallagher WM; Müller-Bunz H; Pampillón C; Strohfeldt K; Tacke M
J Inorg Biochem; 2006 Sep; 100(9):1479-86. PubMed ID: 16764931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
